Search research articles
Contact Us
Filters
Showing results (331-340 of 422) with videos related to
Page
of 43
Sort By:
Neuro-Oncology
|
October 10, 2015
Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study
Nicholas Butowski, Howard Colman, John F De Groot, et al.
Acta Neuropathologica Communications
|
March 19, 2024
Molecular and clinicopathologic characteristics of CNS embryonal tumors with BRD4::LEUTX fusion
Felipe Andreiuolo, Christina K Ferrone, Sharika Rajan, et al.
Acta Neuropathologica
|
February 14, 2018
Deep sequencing of WNT-activated medulloblastomas reveals secondary SHH pathway activation
J Bryan Iorgulescu, Jessica Van Ziffle, Meredith Stevers, et al.
The American Journal of Surgical Pathology
|
January 12, 2018
Sellar Region Atypical Teratoid/Rhabdoid Tumors (ATRT) in Adults Display DNA Methylation Profiles of the ATRT-MYC Subgroup
Pascal D Johann, Susanne Bens, Florian Oyen, et al.
Acta Neuropathologica
|
March 11, 2015
Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers
Andrey Korshunov, Marina Ryzhova, Volker Hovestadt, et al.
Acta Neuropathologica
|
February 1, 2022
High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13
Drew Pratt, Zied Abdullaev, Antonios Papanicolau-Sengos, et al.
Brain Pathology (Zurich, Switzerland)
|
May 27, 2025
cIMPACT-NOW update 10: Recommendations for defining new types for central nervous system tumor classification
Cynthia Hawkins, Kenneth Aldape, David Capper, et al.
Neuro-Oncology
|
March 25, 2017
A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study
Anuradha Banerjee, Regina I Jakacki, Arzu Onar-Thomas, et al.
Acta Neuropathologica
|
November 20, 2012
LIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR)
Andrey Korshunov, Marina Ryzhova, David T W Jones, et al.
Nature Genetics
|
May 17, 2024
Spatial genomic, biochemical and cellular mechanisms underlying meningioma heterogeneity and evolution
Calixto-Hope G Lucas, Kanish Mirchia, Kyounghee Seo, et al.
Page
of 43
Search research articles
Search
Showing results (331-340 of 422) with videos related to
Sort By:
Page
of 43
Neuro-Oncology
|
October 10, 2015
Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study
Nicholas Butowski, Howard Colman, John F De Groot, et al.
Acta Neuropathologica Communications
|
March 19, 2024
Molecular and clinicopathologic characteristics of CNS embryonal tumors with BRD4::LEUTX fusion
Felipe Andreiuolo, Christina K Ferrone, Sharika Rajan, et al.
Acta Neuropathologica
|
February 14, 2018
Deep sequencing of WNT-activated medulloblastomas reveals secondary SHH pathway activation
J Bryan Iorgulescu, Jessica Van Ziffle, Meredith Stevers, et al.
The American Journal of Surgical Pathology
|
January 12, 2018
Sellar Region Atypical Teratoid/Rhabdoid Tumors (ATRT) in Adults Display DNA Methylation Profiles of the ATRT-MYC Subgroup
Pascal D Johann, Susanne Bens, Florian Oyen, et al.
Acta Neuropathologica
|
March 11, 2015
Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers
Andrey Korshunov, Marina Ryzhova, Volker Hovestadt, et al.
Acta Neuropathologica
|
February 1, 2022
High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13
Drew Pratt, Zied Abdullaev, Antonios Papanicolau-Sengos, et al.
Brain Pathology (Zurich, Switzerland)
|
May 27, 2025
cIMPACT-NOW update 10: Recommendations for defining new types for central nervous system tumor classification
Cynthia Hawkins, Kenneth Aldape, David Capper, et al.
Neuro-Oncology
|
March 25, 2017
A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study
Anuradha Banerjee, Regina I Jakacki, Arzu Onar-Thomas, et al.
Acta Neuropathologica
|
November 20, 2012
LIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR)
Andrey Korshunov, Marina Ryzhova, David T W Jones, et al.
Nature Genetics
|
May 17, 2024
Spatial genomic, biochemical and cellular mechanisms underlying meningioma heterogeneity and evolution
Calixto-Hope G Lucas, Kanish Mirchia, Kyounghee Seo, et al.
Page
of 43